Generic Name:
incobotulinumtoxin A
Project Status:
Active
Therapeutic Area:
Chronic sialorrhea associated with neurological disorders
Manufacturer:
Merz Pharmaceuticals GMBH
Call for patient/clinician input open:
Brand Name:
Xeomin
Project Line:
Reimbursement Review
Project Number:
SR0678-000
Call for patient/clinician input closed:
Details
Manufacturer Requested Reimbursement Criteria1:
For the treatment of chronic sialorrhea associated with neurological disorders in adults.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the treatment of chronic sialorrhea associated with neurological disorders in adults.
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.